Back to Search Start Over

Successful immunoglobulin treatment in a patient with neuromyotonia.

Authors :
Alessi G
De Reuck J
De Bleecker J
Vancayzeele S
Source :
Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2000 Sep; Vol. 102 (3), pp. 173-5.
Publication Year :
2000

Abstract

Neuromyotonia is characterized by spontaneous and continuous muscle fibre activity leading to muscle cramps, pseudomyotonia, myokymia and weakness. Electromyographic recordings show typical findings. An auto-immune mechanism has been suggested in at least a subset of patients. Various therapies have been tried with different outcome. A patient with neuromyotonia responding well to high-dose immunoglobulin treatment is presented.

Subjects

Subjects :
Autoimmunity
Dose-Response Relationship, Drug
Drug Administration Schedule
Electromyography
Humans
Immunoglobulins, Intravenous administration & dosage
Isaacs Syndrome etiology
Isaacs Syndrome immunology
Isaacs Syndrome physiopathology
Male
Middle Aged
Polyneuropathies complications
Remission Induction
Immunoglobulins, Intravenous therapeutic use
Isaacs Syndrome drug therapy

Details

Language :
English
ISSN :
0303-8467
Volume :
102
Issue :
3
Database :
MEDLINE
Journal :
Clinical neurology and neurosurgery
Publication Type :
Academic Journal
Accession number :
10996718
Full Text :
https://doi.org/10.1016/s0303-8467(00)00093-7
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details